Twitter

Archive for the ‘Cancer Bulletins’ Category


Video Explains Realities of CPR for Patients with Advanced Cancer

Cardiopulmonary resuscitation (CPR) does not revive most people with advanced cancer, and those who do survive often experience medical complications. A new study suggests that an educational video may help physicians communicate this information to patients in a meaningful way.

Read More...

U.S. Cancer Deaths Continue Long-Term Decline

According to the latest national data, overall death rates from cancer declined from 2000 through 2009 in the United States, maintaining a trend seen since the early 1990s.

Read More...

Substitute for Drug in Short Supply Found to Be Inferior

Several members of the Pediatric Hodgkin Lymphoma Consortium recently reported poorer outcomes among patients whose treatment regimens had been modified because of drug shortages.

Read More...

Newly Discovered Gene Linked to Hepatitis C Virus Clearance, Treatment Response

Researchers have identified a genetic variant that is strongly associated with the ability to spontaneously clear infection with the hepatitis C virus (HCV) and with the response to treatment for chronic HCV infection, the leading cause of liver cancer in the United States.

Read More...

New Videos from NCI: "Understanding Your Cancer Prognosis"

NCI has released a series of five videos for patients and their health care teams about how to understand and talk about cancer prognosis.

Read More...

NIH Radio: Dr. Barry Kramer on Cancer Screening

The director of NCI’s Division of Cancer Prevention and editor-in-chief of NCI’s Physician Data Query Screening and Prevention Editorial Board talks with NIH Radio about cancer screening and the risks that are sometimes associated with cancer screening.

Read More...

Genetic Mutations Alone Do Not Dictate Cancer Cell Behavior

In laboratory experiments, researchers have found that colorectal tumor cells grown from a single cell behaved very differently, even though the cells were genetically identical. These findings, published last month in Science, suggest that cancer treatments may fail to eradicate tumors for reasons other than the standard rationale that cancer cells acquire more genetic changes as they multiply.

Read More...

Following Up on Genetic Study, Researchers Identify Potential Therapy for Bladder Cancer

In a recent study of bladder cancer, NCI researchers identified a genetic variant associated with a modest increase in risk of the disease. But, after investigating the biologic effects of the variant on cells, the researchers now believe that the variant could be a marker for identifying patients who may respond to an experimental therapy being tested in other cancers.

Read More...

Experimental Drug for Relapsed or Resistant Ovarian Cancer

The name of the trial is Phase II Study of Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (NCI-12-C-0191).

Read More...

Drug Combination Could Help Treat Deadly Form of Thyroid Cancer

New findings from cell and animal studies suggest that combination therapy with two anticancer drugs, paclitaxel and pazopanib, may help treat anaplastic thyroid cancer (ATC), a rare and deadly form of thyroid cancer.

Read More...